1.
Nazha A, Romo CG, Kantarjian H, Cortes J. The clinical impact of ponatinib on the risk of bleeding in patients with chronic myeloid leukemia. Haematologica 2013; 98(10):e131-e131; https://doi.org/10.3324/haematol.2013.091678.